AbbVie reported $9M in Interest Income for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Income Change
Biogen BIIB:US USD 23.9M 11.3M
BioMarin Pharmaceutical BMRN:US USD 5M 2.49M
Eli Lilly LLY:US USD 20.1M 9.9M
Endo International ENDP:US USD 178K 31K
Jazz Pharmaceuticals JAZZ:US USD 3.5M 2.8M
Pacira PCRX:US USD 1.23M 982K
Pfizer PFE:US USD 70M 40M
Revance Therapeutics RVNC:US USD 1.16M 546K
Ultragenyx Pharmaceutical RARE:US USD 3.48M 2.58M
United Therapeutics UTHR:US USD 13.3M 6.5M
Vertex Pharmaceuticals VRTX:US USD 46.2M 35.4M